has the fda approved semaglutide for weight loss A big win Wegovy: drug first in history to gain approval for reducing heart risks FDA approves weight-loss drug Wegovy

By administrator July 8, 2024 Blog Semaglutide (brandname: Wegovy, Ozempic ) is a medicine which when combined with lifestyle interventions, has shown to cause a sustained and clinically relevant reduction in body weight by 5-15%

The new generation of appetite-suppressing drugs using GLP-1 agonists -- which include the brands Ozempic, Wegovy and Mounjaro -- have exploded in popularity in recent years due to their ability to help people lose weight

Side effects can quickly lead to dehydration, frailty, falls, or problems during procedures

Lifestyle Factors: Sleep, Stress, and Cortisol Poor sleep and chronic stress boost cortisol, a hormone that promotes fat storage, particularly around the midsection

Nothing in this article should be construed as a recommendation to diagnose, treat, cure, or prevent any disease or medical condition, nor as guidance on prescribing or administering any pharmaceutical compound to any specific patient